论文部分内容阅读
异体血液输注 ( HBT)对机体免疫有抑制作用 ,可对肿瘤病人的预后造成不良影响。自体血液输注 ( ABT)在矫形手术及心血管病人中应用较多 ,而在胃肠道与肝肿瘤手术病人中应用尚少。作者观察了 ABT与重组人红细胞生成素 ( rh- EPO)联合用于肝细胞癌手术病人的效果及存在的问题。病
Allogeneic blood transfusion (HBT) has an inhibitory effect on the body’s immune system and can have a negative impact on the prognosis of cancer patients. Autologous blood transfusion (ABT) is widely used in orthopedic surgery and cardiovascular patients, but it is rarely used in gastrointestinal and liver cancer patients. The authors observed the efficacy and problems of ABT combined with recombinant human erythropoietin (rhEPO) in patients with hepatocellular carcinoma. disease